Arizona Medical Board
1740 W. Adams Street, Suite 4000
Phoenix, AZ 85007
Phone: (480) 551-2700 Fax: (480) 551-2702
Website: www.azmd.gov
DATA Waiver Eligibility Fact Sheet
Effective August 27, 2019, the Board will begin accepting the DATA Waiver Eligibility application pursuant to the Drug Addiction
Treatment Act of 2000 (DATA Waiver Eligibility) to practice opioid use disorder treatment in an outpatient facility.
A completed application must be submitted in PDF format to Michelle.Robles@azmd.gov.
The application must not be more than 10 pages.
Board Staff will review the application for completeness and place it on the Board’s agenda for
review and action. A public meeting notice letter will be sent to the address on the application
informing the applicant of date and time of review by the Board. Please be aware that an
incomplete application will be considered deficient and will not move forward for review by the
Board until all required information is received.
If approved by the Board, the training facility shall submit a list in Excel format with the name and
address of all recipients of the training indicating they’ve met the requirements of the Board
approved curriculum/training and that they are DATA Waiver Eligible. Upon receipt of the list of
names the Board will issue a written notice to each qualified physician.
Example of Excel format:
Upon receipt of the full DEA license, a physician with an approval letter for DATA waiver from
the Board may submit the Board letter to SAMHSA for approval at
http://buprenorphine.samhsa.gov/forms/select-practitioner-type.php.
If the initial application is denied, the Board will send written notice informing applicant of the
action. There may be a single appeal for reconsideration of the waiver application.